Calliditas Therapeutics AB (publ)
SSE:CALTX.ST
107.8 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -466.185 | -421.943 | -524.456 | -379.72 | -28.019 | -132.482 | -84.509 | -56.02 | -50.911 |
| Depreciation & Amortization
| 16.594 | 12.913 | 34.433 | 2.823 | 1.822 | 0.051 | 0.051 | 0.112 | 0.111 |
| Deferred Income Tax
| 0 | 0 | -65.672 | 7.625 | 0.776 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 52.591 | 35.791 | 21.96 | 6.012 | 0.249 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -79.741 | 88.42 | 5.47 | 54.083 | -45.901 | 4.242 | 16.181 | 0.371 | 1.99 |
| Accounts Receivables
| -182.589 | -91.878 | -11.712 | 8.033 | -53.546 | 2.642 | -1.885 | 0.052 | -1.185 |
| Inventory
| -16.781 | -2.758 | -0.949 | 0 | 45.901 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 119.629 | 183.056 | 18.131 | 46.05 | 7.645 | 1.6 | 18.066 | 0.319 | 3.176 |
| Other Working Capital
| -79.74 | 183.056 | 18.131 | 0 | -45.901 | 1.6 | 18.066 | 0.319 | 3.175 |
| Other Non Cash Items
| 207.606 | -26.535 | 66.677 | -0.004 | 0.062 | 0.049 | 0.321 | 0.216 | 0.009 |
| Operating Cash Flow
| -434.655 | -311.354 | -461.588 | -309.181 | -71.011 | -128.191 | -68.007 | -55.433 | -48.912 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -12.787 | -2.512 | -22.654 | 0 | -16.184 | 0 | 0 | -0.256 | 0 |
| Acquisitions Net
| 0 | 0 | -47.021 | -172.602 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -1.56 | -2.633 | -1.686 | -0.005 | -1.888 | 0 | -0.05 | 0 | -0.29 |
| Sales Maturities Of Investments
| 0.602 | 0 | 71.361 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.001 | 0.001 | -24.34 | -172.607 | -17.954 | 0 | -0.05 | 0 | -0.29 |
| Investing Cash Flow
| -13.745 | -5.144 | -24.34 | -172.607 | -18.072 | 0 | -0.05 | -0.256 | -0.29 |
| Financing Activities: | |||||||||
| Debt Repayment
| -211.784 | -9.615 | -5.575 | -3.972 | -1.652 | -0.47 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0.236 | 324 | 891.388 | 210.317 | 768.649 | 64.751 | 24.724 | 55.124 |
| Common Stock Repurchased
| 0 | -0.236 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -26.626 | 585.605 | 116.737 | -118.858 | -9.83 | -51.607 | 36.473 | 30 | 0.062 |
| Financing Cash Flow
| 199.65 | 575.99 | 435.162 | 768.558 | 198.835 | 716.572 | 101.224 | 54.724 | 55.186 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -26.611 | 34.094 | 9.969 | -44.006 | -2.387 | 0.442 | -0.056 | 0.044 | -0.019 |
| Net Change In Cash
| -275.361 | 293.587 | -40.797 | 242.764 | 97.365 | 588.823 | 33.111 | -0.921 | 5.965 |
| Cash At End Of Period
| 973.733 | 1,249.094 | 955.507 | 996.304 | 753.54 | 646.175 | 57.352 | 24.241 | 25.162 |